exogen™ Pro Line is an exclusive brand proudly produced by C3 Global Biosciences, Inc. Our line was developed to support physicians and other professionals who have their patients best interest at heart and are committed to better health and wellness. These products can’t be found anywhere else as each formulation uses carefully selected ingredients and is always manufactured at therapeutic levels and potencies. At c3GBS we are here to serve and support healthcare providers and professionals with the safest and highest quality Cannabidiol (CBD) products. This program not only will benefit your clients, you will have the ability to grow and expand your business.

QUESTION
OF THE DAY

How Is The Endocannabinoid System Involved In Epilepsy?

There are defects in the endocannabinoid system in persons with epilepsy.

In one study, 12 patients with newly diagnosed temporal lobe epilepsy had lower levels (p < .01) of anandamide in CSF as compared to controls. In tissue removed from 30 patients undergoing epilepsy surgery, the levels of CB1 receptor messenger RNA were lower in some excitatory nerve endings as compared to the specimens obtained postmortem from persons without epilepsy.

It was also noted that in the epilepsy patients, there was a reduced expression of diacylglycerol lipase α, the enzyme that synthesizes 2-AG in postsynaptic neurons. (Recall that 2-AG is a fully efficacious agonist of both CB1 and CB2 receptors.)